Your browser doesn't support javascript.
loading
Anti-tumor effects of an ID antagonist with no observed acquired resistance.
Wojnarowicz, Paulina M; Escolano, Marta Garcia; Huang, Yun-Han; Desai, Bina; Chin, Yvette; Shah, Riddhi; Xu, Sijia; Yadav, Saurabh; Yaklichkin, Sergey; Ouerfelli, Ouathek; Soni, Rajesh Kumar; Philip, John; Montrose, David C; Healey, John H; Rajasekhar, Vinagolu K; Garland, William A; Ratiu, Jeremy; Zhuang, Yuan; Norton, Larry; Rosen, Neal; Hendrickson, Ronald C; Zhou, Xi Kathy; Iavarone, Antonio; Massague, Joan; Dannenberg, Andrew J; Lasorella, Anna; Benezra, Robert.
Afiliação
  • Wojnarowicz PM; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Escolano MG; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Huang YH; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Desai B; Weill Cornell/Sloan Kettering/Rockefeller Tri-Institutional MD-PhD Program, New York, NY, 10065, USA.
  • Chin Y; Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, NY, 10065, USA.
  • Shah R; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Xu S; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yadav S; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yaklichkin S; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ouerfelli O; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Soni RK; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Philip J; Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Montrose DC; Proteomics & Microchemistry Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Healey JH; Proteomics & Microchemistry Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rajasekhar VK; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Garland WA; Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA.
  • Ratiu J; Orthopedics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhuang Y; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Norton L; Tosk, Inc., Mountain View, CA, USA.
  • Rosen N; Department of Immunology, Duke University, Durham, NC, USA.
  • Hendrickson RC; Department of Immunology, Duke University, Durham, NC, USA.
  • Zhou XK; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Iavarone A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Massague J; Proteomics & Microchemistry Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Dannenberg AJ; Department of Healthcare Policy and Research Weill Cornell Medical College, New York, NY, USA.
  • Lasorella A; Department of Neurology, Department of Pathology, Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA.
  • Benezra R; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
NPJ Breast Cancer ; 7(1): 58, 2021 May 24.
Article em En | MEDLINE | ID: mdl-34031428

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos